Dr. Erika P Hamilton
Claim this profileSarah Cannon Research Institute
Expert in Breast Cancer
Expert in Ovarian Cancer
55 reported clinical trials
77 drugs studied
About Erika P Hamilton
Education:
- Obtained MD from the University of Tennessee Health Science Center, Memphis, TN.
- Completed Residency in Internal Medicine at Vanderbilt University Medical Center, Nashville, TN.
- Undertook Fellowship in Hematology/Oncology at Vanderbilt University Medical Center, Nashville, TN.
Experience:
- Currently serves as the Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute.
- Specializes in the treatment of breast cancer and gynecologic malignancies.
Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Ovarian Cancer
Global LeaderHER2 positive
Stage IV
HER2 negative
Affiliated Hospitals
Clinical Trials Erika P Hamilton is currently running
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting2 awards Phase 33 criteria
MEN2312
for Breast Cancer
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Recruiting1 award Phase 12 criteria
More about Erika P Hamilton
Clinical Trial Related5 years of experience running clinical trials · Led 55 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Erika P Hamilton has experience with
- Tucatinib
- Fulvestrant
- Placebo
- Trastuzumab
- Paclitaxel
- Pembrolizumab
Breakdown of trials Erika P Hamilton has run
Breast Cancer
Ovarian Cancer
Lung Cancer
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erika P Hamilton specialize in?
Erika P Hamilton focuses on Breast Cancer and Ovarian Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Erika P Hamilton currently recruiting for clinical trials?
Yes, Erika P Hamilton is currently recruiting for 9 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Erika P Hamilton has studied deeply?
Yes, Erika P Hamilton has studied treatments such as Tucatinib, Fulvestrant, Placebo.
What is the best way to schedule an appointment with Erika P Hamilton?
Apply for one of the trials that Erika P Hamilton is conducting.
What is the office address of Erika P Hamilton?
The office of Erika P Hamilton is located at: Sarah Cannon Research Institute, Nashville, Tennessee 37203-1625 United States. This is the address for their practice at the Sarah Cannon Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.